Cetrolix Protocol versus Conventional Clomiphene Citrate Protocol in Women with Unexplained Infertility Undergoing Intrauterine Insemination: A Randomised Prospective Study
Journal Title: Journal of Gynecological Research and Obstetrics - Year 2016, Vol 2, Issue 1
Abstract
Objective: The primary goal of this study was to compare the ovulation and pregnancy rates in women with unexplained infertility undergoing intrauterine insemination utilizing an antagonist (cetrolix) protocol versus the commonly used clomiphene citrate regimen. Patients and Methods: This was a randomized controlled study performed at Assisted Reproductive Techniques Center of Ain Shams University Maternity Hospital, over a 2-year period, between Jan 2014 and Jan 2016, and included 80 women,with unexplained infertility undergoing intrauterine insemination (IUI), were randomised into two groups. Group I (n=40) received the antagonist protocol: human menopausal gonadotropins were given from Day 2 to reach a dominant follicle of 18-22 mm, intramuscularly. Then, cetrolix (0.25 mg) was subcutaneously started from Day 6 or Day 7 until the day of human chorionic gonadotropins (hCG; that was given in the dose of 10,000 IU, intramuscularly) when follicles reached 18-22 mm. Group II (n=40) receivd the clomiphene citrate protocol: clomiphene citrate given 100 mg/d from Day 2 to Day 6 and then human menopausal gonadotropin (hMG) to reach a dominant follicle of 18-22 mm, intramuscularly. Follow up until day of hCG, afterward, the IUI of 0.5 mL was done from 34 hours to 36 hours using IUI catheter without guidance of ultrasonography and with an empty urinary bladder. The primary outcome was clinical pregnancy rate defined as the presence of intrauterine gestational sac detected by ultrasound at 5-weeks’ gestation . The number of dominant follicles, level of serum estradiol, and luteinizing hormone at the day of hCG injection and the incidence of twin or triplet pregnancies in both groups were secondary outcome measures. Results: In this study Conclusions: It seems that clinical pregnancy rates were significantly higher by cetrolix protocol
Authors and Affiliations
F Mostafa, L Farid
Keywords
Related Articles
- EP ID EP337106
- DOI 10.17352/jgro.000023
- Views 91
- Downloads 0
Human zygote reconstruction by spindle, polar body or pronuclear transfer to treat repeated embryo fragmentation or embryo developmental arrest: the future is now
A common and very difficult issue to overcome as a clinical embryologist during an IVF cycle is the event of severe embryonic fragmentation or, more rarely, full developmental arrest. The current approach to bypass these...
Human Papilloma Virus vaccine –awareness and acceptability amongst medical students in a tertiary teaching hospital in South India
Objectives: To evaluate awareness and acceptability of HPV vaccine amongst medical students in a tertiary teaching hospital. Materials and methods: This was a cross sectional descriptive study carried out in a tertiary...
Prediction of Ovarian Response by Antimullerian Hormone in Women with Polycystic Ovarian Syndrome: A Randomized Prospective Study
Objective: To assess the effect of high level of circulating antimullerian hormone on the outcome of gonadotrophin ovulation induction in women with polycystic ovarian syndrome. Patients and Methods: This was a prospecti...
Hospital Acquired Obstetrical Infections
“One drop of its water reflects the whole ocean.” The December 2, 2015 issue of the “American Medical Association Morning Rounds” reminded me to this old dictum. It announced that as a result of coordinated efforts by se...
Ovarian Ectopic Pregnancy after Endometriomal Cyst Resection, Following In vitro Fertilization (IVF): A Rare Case Report
Background: primary ectopic pregnancy (EP), with 0.001-0.013% incidence rate, is a very scarce obstetrical condition. Among EPs Ovarian EP is more rarely seen? Case: We present a case of ovarian EP following In vitro fe...